Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

GenMark Diagnostics Inc. (GNMK)

7   0.08 (1.16%) 04-18 16:00
Open: 6.89 Pre. Close: 6.92
High: 7.02 Low: 6.72
Volume: 307,101 Market Cap: 395M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.023 - 7.066 7.066 - 7.106
Low: 6.622 - 6.671 6.671 - 6.718
Close: 6.923 - 6.997 6.997 - 7.068

Technical analysis

as of: 2019-04-18 4:36:25 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 8.53     One year: 9.02
Support: Support1: 6.62    Support2: 5.51
Resistance: Resistance1: 7.30    Resistance2: 7.72
Pivot: 7.23
Moving Average: MA(5): 7.24     MA(20): 7.22
MA(100): 6.21     MA(250): 6.53
MACD: MACD(12,26): 0.03     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 38.25     %D(3): 50.81
RSI: RSI(14): 44.24
52-week: High: 8.81  Low: 3.58  Change(%): 14.0
Average Vol(K): 3-Month: 38553  10-Days: 29443

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
GNMK has closed above bottom band by 19.6%. Bollinger Bands are 44.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to GNMK's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 22 Feb 2019 03:11:51 Z
GenMark Diagnostics Inc (GNMK) Q4 2018 Earnings Conference Call Transcript

Fri, 22 Feb 2019 00:11:08 Z
GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates

Thu, 14 Feb 2019 17:43:42 Z
Will GenMark Diagnostics (GNMK) Report Negative Earnings Next Week? What You Should Know

Wed, 26 Dec 2018 14:47:15 Z
Health Care Sector Update for 12/26/2018: GNMK, TEVA, CAPR, JNJ, PFE, ABT, MRK, AMGN

Tue, 30 Oct 2018 00:10:25 Z
GenMark Diagnostics (GNMK) Reports Q3 Loss, Tops Revenue Estimates

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 56.47
Shares Float (M) 52.49
% Held by Insiders
% Held by Institutions 152.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.920
EPS Est. Current Year -1.070
EPS Est. Next Year -0.690
EPS Est. Next Quarter -0.140
Forward EPS -0.630
Book Value (p.s.) 12.310
PEG Ratio 0.22
Profit Margin -77.68
Operating Margin -67.51
Return on Assets (ttm) -48.1
Return on Equity (ttm) -99.3
Qtrly Rev. Growth 20.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -32.51
Levered Free Cash Flow (M) -13.60

Stock Valuations

P/E -7.61
P/E Growth Ratio 0.01
P/BV 0.57
P/S 311251968.00
P/CF -12.16

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.